New insulin algorithm aims to tame type 2 diabetes
NCT ID NCT07039981
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a next-generation automated insulin delivery system in 48 adults with type 2 diabetes aged 16–70. The goal was to see if the smart algorithm could keep blood sugar in a safer range, reducing both low and high blood sugar events. Participants used a continuous glucose monitor and insulin pump. The results help improve daily diabetes management, but the condition still requires ongoing care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Otago, Christchurch
Christchurch, 8011, New Zealand
-
Wellington Regional Hospital
Wellington, 6021, New Zealand
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Daily pill could offer new hope for weight loss in east asian adults
- FitBit coaching may help amputees walk more after surgery
- Blood test could predict who faces rapid kidney decline in diabetes
- Blood test may predict kidney decline in diabetes — a large trial investigates
- Hormone clue may unmask kidney danger in diabetes
- Can a single pill tackle both fatty liver and diabetes?